Concepedia

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

Jeffrey M. Witkin, S.N. Mitchell, Keith A. Wafford, G. Carter, Gary Gilmour, Jinrong Li, Brian J. Eastwood, C. Overshiner, X. Li, Linda Rorick‐Kehn,

Journal of Pharmacology and Experimental Therapeutics · 2017 · 43 citations · 58 references

References

58

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate, Jaskaran Singh, Paul J. Carlson et al. · Archives of General Psychiatry · 2006 · 3.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Nanxin Li, Boyoung Lee, Rongjian Liu et al. · Science · 2010 · 2.9K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos, Ruin Moaddel, Patrick J. Morris et al. · Nature · 2016 · 1.6K citations · Full text

Medicine, Neuroscience, Pharmacology +14

MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis

Jianguo Xia, Raju K. Mandal, I. Sinelnikov et al. · Nucleic Acids Research · 2012 · 1.2K citations · Full text

Life Sciences, Biochemistry, Bioinformatics +17

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Sungho Maeng, Carlos A. Zarate, Jing Du et al. · Biological Psychiatry · 2007 · 1.1K citations

Medicine, Neuroscience, Pharmacology +16